| Gregory Neel, MD | |
|
410 Celebration Pl Ste 305, Celebration, FL 34747-5436 | |
| (407) 303-4120 | |
| (407) 303-4124 |
| Full Name | Gregory Neel |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 10 Years |
| Location | 410 Celebration Pl Ste 305, Celebration, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164832036 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Adventhealth Daytona Beach | Daytona beach, FL | Hospital |
| Adventhealth New Smyrna Beach | New smyrna beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Medical Group Inc | 0749186153 | 1163 |
News Archive
Eggland's Best, Inc. (EB) is proud to support Susan G. Komen for the Cure®, the world's largest breast cancer advocacy organization. For the first time in the brand's history, Eggland's Best will display the Komen for the Cure's running ribbon logo along with a pink version of their iconic "EB" stamp on their egg varieties during the autumn of 2010.
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
The Pancreatic Cancer Action Network, in partnership with the American Association for Cancer Research (AACR), is now accepting applications for the 2010 Research Grants Program. This year's grants program will be administered through the AACR's rigorous peer-review system to ensure the highest quality science is supported. The grant terms will begin on July 1, 2010.
A University of Toronto pilot study that re-conceptualized the hospital labour room by removing the standard, clinical bed and adding relaxation-promoting equipment had a 28 per cent drop in infusions of artificial oxcytocin, a powerful drug used to advance slow labours.
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to use Sutro's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered by Memorial Sloan-Kettering for the treatment of neuroblastoma in children.
› Verified 8 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
Eggland's Best, Inc. (EB) is proud to support Susan G. Komen for the Cure®, the world's largest breast cancer advocacy organization. For the first time in the brand's history, Eggland's Best will display the Komen for the Cure's running ribbon logo along with a pink version of their iconic "EB" stamp on their egg varieties during the autumn of 2010.
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
The Pancreatic Cancer Action Network, in partnership with the American Association for Cancer Research (AACR), is now accepting applications for the 2010 Research Grants Program. This year's grants program will be administered through the AACR's rigorous peer-review system to ensure the highest quality science is supported. The grant terms will begin on July 1, 2010.
A University of Toronto pilot study that re-conceptualized the hospital labour room by removing the standard, clinical bed and adding relaxation-promoting equipment had a 28 per cent drop in infusions of artificial oxcytocin, a powerful drug used to advance slow labours.
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to use Sutro's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered by Memorial Sloan-Kettering for the treatment of neuroblastoma in children.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Neel, MD 410 Celebration Pl Ste 305, Celebration, FL 34747-5436 Ph: (407) 303-4120 | Gregory Neel, MD 410 Celebration Pl Ste 305, Celebration, FL 34747-5436 Ph: (407) 303-4120 |
News Archive
Eggland's Best, Inc. (EB) is proud to support Susan G. Komen for the Cure®, the world's largest breast cancer advocacy organization. For the first time in the brand's history, Eggland's Best will display the Komen for the Cure's running ribbon logo along with a pink version of their iconic "EB" stamp on their egg varieties during the autumn of 2010.
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
The Pancreatic Cancer Action Network, in partnership with the American Association for Cancer Research (AACR), is now accepting applications for the 2010 Research Grants Program. This year's grants program will be administered through the AACR's rigorous peer-review system to ensure the highest quality science is supported. The grant terms will begin on July 1, 2010.
A University of Toronto pilot study that re-conceptualized the hospital labour room by removing the standard, clinical bed and adding relaxation-promoting equipment had a 28 per cent drop in infusions of artificial oxcytocin, a powerful drug used to advance slow labours.
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to use Sutro's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered by Memorial Sloan-Kettering for the treatment of neuroblastoma in children.
› Verified 8 days ago
Dr. Bruce Harwood Haughey, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 | |
Dr. Uthman Abdulrahman Alamoudi, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 | |
Michael D. Seidman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 | |
Dr. Andrea Costantino, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 689-280-6805 | |
Dr. Fawaz Mohammedmakki Hassan Makki, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 | |
Dr. Mathew Biskup, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 410 Celebration Pl Ste 100, Celebration, FL 34747 Phone: 321-939-3000 Fax: 321-939-3001 |